These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10472162)

  • 1. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.
    Badia X; Monserrat S; Roset M; Herdman M
    Qual Life Res; 1999 Jun; 8(4):303-10. PubMed ID: 10472162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inconsistent responses in three preference-elicitation methods for health states.
    Badia X; Roset M; Herdman M
    Soc Sci Med; 1999 Oct; 49(7):943-50. PubMed ID: 10468398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility, reliability, and validity of three health-state valuation methods using multiple-outcome vignettes on moderate-risk pregnancy at term.
    Bijlenga D; Birnie E; Bonsel GJ
    Value Health; 2009; 12(5):821-7. PubMed ID: 19508667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.
    Kim SH; Lee SI; Jo MW
    Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.
    Craig BM; Busschbach JJ; Salomon JA
    Med Care; 2009 Jun; 47(6):634-41. PubMed ID: 19433996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
    Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning effects in time trade-off based valuation of EQ-5D health states.
    Augestad LA; Rand-Hendriksen K; Kristiansen IS; Stavem K
    Value Health; 2012; 15(2):340-5. PubMed ID: 22433766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measuring preferences for depressive health states].
    König HH; Bernert S; Angermeyer MC
    Psychiatr Prax; 2005 Apr; 32(3):122-31. PubMed ID: 15818528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated current health time-trade-off assessments in women's health.
    Tosteson AN; Kneeland TS; Nease RF; Sumner W
    Value Health; 2002; 5(2):98-105. PubMed ID: 11918825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
    Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
    BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.
    Augestad LA; Rand-Hendriksen K; Stavem K; Kristiansen IS
    Qual Life Res; 2013 May; 22(4):705-14. PubMed ID: 22678351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity, feasibility and acceptability of time trade-off and standard gamble assessments in health valuation studies: a study in a multiethnic Asian population in Singapore.
    Wee HL; Li SC; Xie F; Zhang XH; Luo N; Feeny D; Cheung YB; Machin D; Fong KY; Thumboo J
    Value Health; 2008 Mar; 11 Suppl 1():S3-10. PubMed ID: 18387064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating the EQ-5D with time trade off for the German population.
    Greiner W; Claes C; Busschbach JJ; von der Schulenburg JM
    Eur J Health Econ; 2005 Jun; 6(2):124-30. PubMed ID: 19787848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argentine valuation of the EQ-5D health states.
    Augustovski FA; Irazola VE; Velazquez AP; Gibbons L; Craig BM
    Value Health; 2009 Jun; 12(4):587-96. PubMed ID: 19900257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.